Literature DB >> 15694495

Trypanosoma brucei RNA interference in the mammalian host.

Laurence Lecordier1, David Walgraffe, Sara Devaux, Philippe Poelvoorde, Etienne Pays, Luc Vanhamme.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15694495     DOI： 10.1016/j.molbiopara.2004.12.009

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN： 0166-6851            Impact factor:   1.759


× No keyword cloud information.
  5 in total

1.  Requirement for acetyl-CoA carboxylase in Trypanosoma brucei is dependent upon the growth environment.

Authors:  Patrick A Vigueira; Kimberly S Paul
Journal:  Mol Microbiol       Date:  2011-02-16       Impact factor: 3.501

2.  The cell cycle as a therapeutic target against Trypanosoma brucei: Hesperadin inhibits Aurora kinase-1 and blocks mitotic progression in bloodstream forms.

Authors:  Neal Jetton; Karen G Rothberg; James G Hubbard; John Wise; Yan Li; Haydn L Ball; Larry Ruben
Journal:  Mol Microbiol       Date:  2009-03-06       Impact factor: 3.501

3.  Ribose 5-phosphate isomerase B knockdown compromises Trypanosoma brucei bloodstream form infectivity.

Authors:  Inês Loureiro; Joana Faria; Christine Clayton; Sandra Macedo-Ribeiro; Nuno Santarém; Nilanjan Roy; Anabela Cordeiro-da-Siva; Joana Tavares
Journal:  PLoS Negl Trop Dis       Date:  2015-01-08

4.  RNA interference of Trypanosoma brucei cathepsin B and L affects disease progression in a mouse model.

Authors:  Maha-Hamadien Abdulla; Theresa O'Brien; Zachary B Mackey; Mohamed Sajid; Dennis J Grab; James H McKerrow
Journal:  PLoS Negl Trop Dis       Date:  2008-09-24

5.  Trypanosoma brucei histone H1 inhibits RNA polymerase I transcription and is important for parasite fitness in vivo.

Authors:  Ana C Pena; Mafalda R Pimentel; Helena Manso; Rita Vaz-Drago; Daniel Pinto-Neves; Francisco Aresta-Branco; Filipa Rijo-Ferreira; Fabien Guegan; Luis Pedro Coelho; Maria Carmo-Fonseca; Nuno L Barbosa-Morais; Luisa M Figueiredo
Journal:  Mol Microbiol       Date:  2014-07-14       Impact factor: 3.501
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.